Literature DB >> 9294389

Review of the screening history of Alberta women with invasive cervical cancer.

G C Stuart1, S E McGregor, M A Duggan, J G Nation.   

Abstract

OBJECTIVE: To conduct a failure analysis of cervical cancer screening among women with invasive cervical cancer in Alberta.
DESIGN: Descriptive study. Review of demographic, staging and treatment information from cancer registry records; generation of documented screening history from Alberta Health billing records and self-reported history from subjects who agreed to be interviewed; and comparison of findings in initial cytology reports with those from subsequent review by at least 2 pathologists of all cytology slides for each patient for the 5 years before diagnosis. Cases were assigned to 1 of 6 categories of identified screening failure.
SETTING: Alberta.
SUBJECTS: All women with diagnosis of invasive cervical cancer reported to a population-based provincial cancer registry from January 1990 to December 1991. OUTCOME MEASURES: Demographic, staging and treatment information; documented and self-reported screening histories; correlation of test results in initial cytology report with those generated from slide review; category of identified screening failure.
RESULTS: Of the 246 women identified with invasive cancer of the cervix, 37 (15.0%) had stage IA disease; 195 (79.3%) had squamous-cell carcinoma, and 35 (14.2%) had adenocarcinoma. According to the categories of screening failure, 74 women (30.1%) had never been screened, 38 (15.4% had not been screened within 3 years before diagnosis, 42 (17.1%) had had a false-negative cytology result, and 20 (8.1%) had been managed outside of conventional protocols. Of the 23 women (9.3%) who had been screened appropriately and had true-negative results, 19 had smears that were considered technically limited. It was not possible to classify 49 (19.9%) of the cases. Agreement between the documented and the self-reported screening histories was exact for only 39 (36.1%) of the 108 women interviewed.
CONCLUSIONS: Despite widespread use of opportunistic cervical screening, many women in Alberta are still not being screened adequately. In most cases women are being screened too infrequently or not at all. Self-reported screening histories are unreliable because many women may overestimate the number of smears. An organized approach to screening, as recommended by the National Workshop in Cervical Cancer Screening, may assist in reducing the incidence of invasive cervical cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9294389      PMCID: PMC1227964     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  9 in total

Review 1.  Report of a National Workshop on Screening for Cancer of the Cervix.

Authors:  A B Miller; G Anderson; J Brisson; J Laidlaw; N Le Pitre; P Malcolmson; P Mirwaldt; G Stuart; W Sullivan
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  New gynecologic cancer staging.

Authors:  W T Creasman
Journal:  Gynecol Oncol       Date:  1995-08       Impact factor: 5.482

3.  Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991.

Authors:  K Sigurdsson
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

4.  The cytologic history of 245 patients developing invasive cervical carcinoma.

Authors:  J A Carmichael; J F Jeffrey; H D Steele; I D Ohlke
Journal:  Am J Obstet Gynecol       Date:  1984-03-01       Impact factor: 8.661

5.  Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix.

Authors:  A G Benoit; G V Krepart; R J Lotocki
Journal:  Am J Obstet Gynecol       Date:  1984-03-01       Impact factor: 8.661

6.  A comparison of physician and patient reports of Pap smear histories.

Authors:  S D Walter; E A Clarke; J Hatcher; L W Stitt
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

7.  The screening histories of women with invasive cervical cancer, Connecticut.

Authors:  D T Janerich; O Hadjimichael; P E Schwartz; D M Lowell; J W Meigs; M J Merino; J T Flannery; A P Polednak
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

8.  Agreement between patient self-reports and medical records for Pap smear histories.

Authors:  M T McKenna; M Speers; K Mallin; R Warnecke
Journal:  Am J Prev Med       Date:  1992 Sep-Oct       Impact factor: 5.043

9.  Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.

Authors:  P D Sasieni; J Cuzick; E Lynch-Farmery
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  9 in total
  9 in total

1.  Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS).

Authors:  C J Maxwell; C M Bancej; J Snider; S A Vik
Journal:  Can J Public Health       Date:  2001 Mar-Apr

2.  Vaginal self sampling versus physician cervical sampling for HPV among younger and older women.

Authors:  T Karwalajtys; M Howard; J W Sellors; J Kaczorowski
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

3.  Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec.

Authors:  A R Spence; A Alobaid; P Drouin; P Goggin; L Gilbert; D Provencher; P Tousignant; J A Hanley; E L Franco
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

4.  Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.

Authors:  G S Ogilvie; D M Patrick; M Schulzer; J W Sellors; M Petric; K Chambers; R White; J M FitzGerald
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

Review 5.  Pap test results. Responding to Bethesda system reports.

Authors:  T J Colgan
Journal:  Can Fam Physician       Date:  2001-07       Impact factor: 3.275

6.  Papanicolaou test utilization and frequency of screening opportunities among women diagnosed with cervical cancer.

Authors:  Kathleen Decker; Alain Demers; Daniel Chateau; Grace Musto; Zoann Nugent; Robert Lotocki; Marion Harrison
Journal:  Open Med       Date:  2009-08-11

7.  Cervical cancer in 2 women with a Mirena(R)-pitfalls in the assessment of irregular bleeding: a case series.

Authors:  Sabina de Weerd; Pieter J Westenend; Sjarlot Gs Kooi
Journal:  Cases J       Date:  2008-07-26

8.  Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.

Authors:  Marta Castillo; Aurora Astudillo; Omar Clavero; Julio Velasco; Raquel Ibáñez; Silvia de Sanjosé
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

9.  Impact of prior underinsurance on cervical cancer screening among Davidson County, Tennessee, women diagnosed with invasive cervical cancer, 2008-2018.

Authors:  Emmanuel N S Sackey; Manideepthi Pemmaraju; Marie R Griffin; Jessica L Castilho
Journal:  BMC Womens Health       Date:  2022-03-12       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.